Life Insurance
Consensus Index

AI Consensus Fit Review

Guardian Life Whole Life Insurance Fit Review for High Early Cash Value

Guardian Life is a good fit for Whole Life Insurance for High Early Cash Value, but the fit is illustration-dependent rather than guaranteed.

Research: 2026-09-207 usable platform responsesRead the methodology ↗

Share

Answer Capsule

Guardian Life is a good fit for Whole Life Insurance for High Early Cash Value, but the fit is illustration-dependent rather than guaranteed. All seven platforms that named Guardian in the ranking stage placed it in their recommendations, with an average listed rank of 2.14 and a best rank of 1. The strongest reason to consider Guardian is its participating whole life framework built around the Paid-Up Additions Rider, limited-pay designs, and a mutual insurer with a long dividend history. The main limitation is that Guardian publishes no standardized early-year cash value schedule or consumer price, and some policies may show little or no cash value in the first two years.

Research Snapshot

FieldDetail
Platform mentions in ranking stage7 of 7 included platforms
Share of included platform responses100%
Average listed rank2.14
Best listed rank1
Relevant product/model/planParticipating Guardian Whole Life with the Paid-Up Additions Rider; limited-pay designs (10-, 15-, 20-pay, L95, L99, L121); Executive Strategies Whole Life; Index Participation Feature where available
Overall use-case fitGood, with significant qualifications
Research date2026-09-20

Why Guardian Life Qualified for This Study

Questions This Section Answers

  • Is Guardian Life a good choice for Whole Life Insurance for High Early Cash Value?
  • Why did Guardian Life qualify for this high early cash value whole life study?

Guardian Life qualified because every platform that named a carrier in the ranking stage named Guardian. Seven platforms — anthropic, deepseek, google, grok, kimi, openai, and perplexity — placed Guardian in their recommendations, giving it a 100% share of included platform responses and an average listed rank of 2.14. Guardian's best listed rank was 1, achieved by anthropic and grok.

The qualification rests on product structure rather than a published price. Guardian publicly lists Whole Life 95, 99, 121, 10-pay, 10-pay Flex, 15-pay, 20-pay, and Executive Wealth Strategies Whole Life for broker distribution [1]. Guardian also describes its Paid-Up Additions Rider, Index Participation Feature, and other life-insurance riders on its own site [2]. That combination — a participating whole life chassis plus a rider designed to purchase additional paid-up insurance — is what the ranking prompt asked for.

Guardian is a mutual insurer, and its financial-highlights page reports ratings of Aa1 from Moody's, A++ from A.M. Best, and AA+ from S&P [3]. Those are company-reported ratings and should be confirmed as current for the issuing legal entity before purchase. Independent reporting also describes Guardian as a policyholder-owned mutual company with no outside shareholders [4].

Qualification does not equal superiority. No supplied evidence establishes that Guardian produces the highest early cash value among competing whole life insurers, and platform agreement on a recommendation is not proof of product quality.

The Product, Model, Plan, or Service Most Relevant to Whole Life Insurance for High Early Cash Value

Questions This Section Answers

  • Which Guardian Life whole life plan is best for a buyer who needs accessible cash value in the first five years?
  • Does Guardian Life's Paid-Up Additions Rider actually accelerate early cash value compared with base premium alone?

The most relevant Guardian design is participating whole life with the Paid-Up Additions Rider, potentially structured as a front-loaded or cash-flow design, with limited-payment versions such as 10-, 15-, or 20-pay as alternatives. Guardian states that its Paid-Up Additions Rider can increase tax-deferred cash value and death benefit, and that larger rider premiums generally provide greater protection [5].

Platforms named several variants. Google pointed to Executive Strategies Whole Life and Whole Life Paid Up at 95 with the Enhanced Paid-Up Additions Rider [7]. Anthropic identified 10-Pay blended with paid-up additions as Guardian's strongest cash-value offering, citing independent analysis [9]. Kimi described Guardian Whole Life with the Enhanced Paid-Up Additions Rider in a front-load or level cashflow design [11]. Perplexity listed ESWL, L95, L99, L121, 10 Pay WL, L20, and L65 with the PUA rider and the Index Participation Feature where available [12].

Product naming is not fully consistent across sources. The requested product names included "Executive Strategies Whole Life" and "Guardian L95 Whole Life with Enhanced Permanent Paid-Up Additions Rider." Guardian's public broker page verifies Executive Wealth Strategies Whole Life and Whole Life 95, but does not verify the exact combined naming or the term "Enhanced Permanent Paid-Up Additions Rider" [13]. One independent product guide states the PUA rider is available on L95, L99, L121, 10 Pay, 15 Pay, 20 Pay, and L65 products [14]. Buyers should confirm the exact policy form and rider names on the application.

What the AI Platforms Agreed About

Questions This Section Answers

  • What do AI platforms agree on about Guardian Life for high early cash value whole life?
  • Is Guardian Life's dividend history relevant to early cash value accumulation?

Agreement was strong on four points, though not unanimous on every detail.

First, the Paid-Up Additions Rider is the core mechanism. Guardian states the rider can increase tax-deferred cash value and death benefit [15]. Independent analysis calls the PUAR essential for any properly designed overfunded policy [17]. One independent analysis adds that the guaranteed interest paid on cash value created by PUAs drives considerable policy growth during the early years, reducing reliance on dividend volatility in that window [19].

Second, Guardian's mutual structure and dividend history are consistent across sources. Guardian states it has paid annual policyholder dividends every year since 1868 and describes paid-up additions as a dividend option [21]. Independent reviews repeat the 1868 figure [22]. For 2026, independent reporting cites a record $1.7 billion dividend allocation at a 6.25% dividend interest rate, up from 6.10% in 2025 and 5.90% in 2024 [24]. Dividends are not guaranteed.

Third, financial strength is reported consistently. Guardian reports Aa1 from Moody's, A++ from A.M. Best, and AA+ from S&P [26]. A.M. Best affirmed an A++ (Superior) financial strength rating as of September 12, 2025, reflecting the strongest level of risk-adjusted capitalization as measured by its BCAR [27].

Fourth, limited-pay designs concentrate premium dollars. Limited-pay whole life compresses payments into a 10- or 20-year window, after which no premiums are due but the policy remains in force [29].

Where the AI Platforms Disagreed or Were Uncertain

Questions This Section Answers

  • How much early cash value does Guardian Life actually deliver in years one through five?
  • Does Guardian Life's Index Participation Feature help or hurt early cash value accumulation?

Platforms diverged on the magnitude of early cash value and on several contract details.

On year-one liquidity, kimi reported that Guardian achieves 80–87% year-one cash value on cashflow designs and 85–94% on front-load designs, calling this among the highest in the industry [30]. Google reported that Executive Strategies Whole Life targets cash value equal to 95% of the annual premium in year one, and L95 targets cash value equal to cumulative annual premium by policy year two [31]. These figures come from third-party distributor and review material, not from Guardian's consumer pages, and they were not independently verified. Other platforms did not confirm them. OpenAI stated plainly that no verified public evidence establishes that Guardian produces the highest early cash value among competing whole life insurers.

On early-year cash value availability, anthropic and openai both flagged that some Guardian whole life policies have no cash value in the first two years and may not pay a dividend until the third year [32]. Which specific products carry that delay is not documented in the supplied sources.

On the Index Participation Feature, terms conflict. Guardian's rider page describes a cap rate currently 10.5% and a floor currently 4% [34]. Perplexity noted that one public source cited a 12.5%/4% cap and floor at launch, while later summaries cite 10.5%/4%, and that current policy terms are unclear without the actual contract illustration [35]. Guardian states the IPF cost is currently 2%, with a guaranteed maximum rate of 3% on the IPF portion [36]. Guardian also states the rider may restrict dividend options and that negative adjustments can reduce cash values relative to not selecting it [33].

On loan treatment, anthropic reported that Guardian uses direct recognition, adjusting the dividend rate on the borrowed portion of cash value, which matters most for frequent-borrowing strategies [38]. Kimi reported a fixed 5% policy loan rate for the first ten years [30], while anthropic reported 6% until the later of age 65 or after the 20th policy year, then 4%, with a variable loan rate option starting in policy year 10 [39]. These loan-rate figures conflict and must be confirmed in the contract.

On long-term tradeoffs, kimi reported that Guardian's long-term internal rate of return trails carriers optimized for multi-decade growth, with Penn Mutual's long-term IRR running roughly 8–21% higher than front-load leaders [30]. Independent analysis cited by kimi found that high-early-cash-value designs show higher IRR in roughly the first ten years, but a normally designed PUA-rich policy pulls ahead by year 20 or later [40].

Use-Case-Specific Features and Capabilities

Questions This Section Answers

  • Which Guardian Life features matter most for a buyer who wants cash value accessible in the early policy years?
  • Can a Guardian Life whole life policy be structured to avoid Modified Endowment Contract status while still front-loading?

The features most relevant to early cash value are the Paid-Up Additions Rider, dividend reinvestment into paid-up additions, limited-pay designs, and the optional Index Participation Feature.

Paid-up additions are the primary accelerator. Guardian states the rider purchases additional paid-up insurance, increasing both cash value and death benefit [41]. One Guardian-linked brochure states the Enhanced Paid-Up Additions Rider allows scheduled and unscheduled payments and varying payments year to year, which supports front-loading when the contract permits it [43]. That brochure is third-party distributor material and should be verified against the illustration and policy contract.

Dividend use is a second lever. Guardian identifies paid-up additions as a dividend option, and reinvesting dividends into PUAs can increase cash value and death benefit, though timing and amount are non-guaranteed [44].

Limited-pay designs are a third lever. Guardian publicly lists 10-pay, 10-pay Flex, 15-pay, and 20-pay whole life for brokers [46]. Independent analysis describes the 10-Pay design as front-loading premium dollars, with blending into PUAs accelerating early cash value growth while keeping the policy below MEC limits [47].

The Index Participation Feature is optional and adds complexity. Guardian describes it as allowing 0% to 100% allocation of paid-up-addition cash value to an index-linked dividend adjustment, subject to a cap and floor [41]. It is available only in approved states and only at issue on select policies [49].

Access to cash value runs through withdrawals or policy loans. Guardian states that loans and withdrawals can reduce policy benefits, and that tax treatment depends on basis, policy status, and whether the contract is a MEC [45]. Adding large amounts of paid-up additions may create a MEC, subjecting distributions to last-in-first-out ordinary income tax treatment and a potential 10% federal penalty on the gain portion if the owner is under age 59½ [51].

Pricing, Fees, Contracts, and Ongoing Costs

Questions This Section Answers

  • How much does Guardian Life whole life cost per month, and what fees apply to the Paid-Up Additions Rider?
  • What surrender charges and loan terms should a buyer confirm before signing a Guardian Life whole life contract?

Pricing confidence is low. No public consumer premium quote or standardized price was verified for the relevant Guardian whole-life designs [52]. Pricing must be individually illustrated and depends on age, sex, tobacco status, health underwriting, face amount, base-policy design, PUA premium, payment period, riders, and state.

The one published anchor is a Guardian rate page stating average whole life rates start at about $225 per month for a $500,000 policy that builds cash value [53]. Independent reporting states Guardian whole life premiums typically run above the industry average [54]. Kimi reported that no Guardian-specific premium quotes were found and that industry-wide benchmarks put a healthy 35-year-old male at roughly $400–600 per month for $500,000 of whole life, with front-load designs requiring first-year premiums two to five times ongoing annual amounts [55]. Those are industry benchmarks, not Guardian quotes.

Known cost components include base whole-life premiums, additional premiums allocated to the Paid-Up Additions Rider, any applicable rider charges including the Index Participation Feature cost if selected, potential policy-loan interest, and the opportunity cost of committing capital to permanent insurance. Guardian states the IPF cost is currently 2% with a guaranteed maximum rate of 3% on the IPF portion [57].

Contract terms to verify include surrender charges, which vary by state and policy and are not publicly detailed [52]. Surrendering early may produce less than total premiums paid. Premiums generally must be paid as required to keep guarantees in force, and limited-payment policies can become paid up after the stated period. Guardian does not offer online policy purchase; every application routes through a licensed financial professional [59].

Best Suited For

Questions This Section Answers

  • Who is Guardian Life best suited for when early cash value matters more than the distant death benefit?
  • Is Guardian Life worth it for a buyer who wants permanent coverage plus accelerated cash accumulation?

Guardian is best suited for a buyer who wants permanent death-benefit guarantees plus the possibility of accelerating cash-value growth with paid-up additions. That buyer should be willing to have an agent or broker compare guaranteed and non-guaranteed illustrations under different base, PUA, and premium-payment designs.

It also suits buyers who value a financially established mutual insurer and potential participating-policy dividends [60]. Platforms specifically named buyers willing to use 10-Pay, 15-Pay, or L95 limited-pay designs with paid-up additions, buyers open to optional index-linked rider features on select policies [61], and buyers who will request in-force illustrations to compare early cash value across designs before buying [61].

Kimi framed the strongest fit as buyers needing maximum liquidity in years one through five, including businesses using whole life as a balance-sheet product, real estate investors who will deploy borrowed capital quickly, and buyers in states where competitors do not sell core whole life [62]. Those positioning claims are platform-reported and rest on third-party review material.

Probably Not Best Suited For

Questions This Section Answers

  • Who should not choose Guardian Life for Whole Life Insurance for High Early Cash Value?
  • Is Guardian Life a poor fit for a buyer who needs immediate full cash value in year one?

Guardian is probably not best for a buyer seeking the lowest-cost way to obtain a large death benefit. It is also a poor fit for a buyer who needs highly predictable liquidity in the first few policy years without accepting front-loaded insurance costs or surrender-value constraints.

Buyers who need immediate full cash value access in year one or two should look carefully, because some Guardian policies have minimal or zero cash values in the first two years [63]. Buyers requiring non-direct-recognition loan treatment for high-frequency borrowing strategies are also flagged as a poor fit [65].

Price-sensitive buyers should note that Guardian whole life premiums typically run above the industry average [66]. Buyers who prefer fully online application and policy management will not find it, since Guardian requires a licensed financial professional [67]. Buyers unwilling to monitor policy loans, dividend assumptions, rider costs, or MEC limits are also a poor match.

When Another Option May Be Better

Questions This Section Answers

  • What is a better alternative to Guardian Life for a buyer who needs non-direct-recognition policy loans?
  • When should a buyer choose a different carrier over Guardian Life for high early cash value?

Another option may be better in several defined situations.

If another participating mutual insurer provides a materially higher guaranteed or illustrated cash-surrender value in years 1 through 10 for the same premium, death benefit, and underwriting assumptions, that carrier deserves the business. If a carrier offers a clearer or more favorable PUA rider, lower rider costs, better loan provisions, or more flexible premium patterns, compare it directly.

If the buyer prioritizes non-direct-recognition policy loan treatment for high-frequency borrowing, platforms named New York Life and Penn Mutual as offering non-direct-recognition options. If the buyer needs the absolute lowest whole life premiums, Guardian's above-average pricing makes other carriers worth quoting [68]. If the buyer needs immediate full cash value in years one or two, other carriers may structure policies with earlier cash value availability.

If the buyer primarily needs inexpensive death-benefit protection, term insurance may be more efficient. If the buyer primarily needs flexible accumulation or liquidity rather than traditional whole life guarantees, other permanent-insurance designs may be worth comparing, subject to separate analysis. Kimi named Penn Mutual or Lafayette Life when long-term IRR maximization matters more than year-one liquidity, Pan-American Life for pure front-load early cash value, and MassMutual Legacy HECV when specific multi-pay designs are preferred [69]. Those comparisons are platform-reported and were not independently verified.

Questions to Verify Before Buying

Questions This Section Answers

  • What should a buyer confirm with Guardian Life before signing a whole life contract?
  • Which Guardian Life illustration details prove the early cash value design actually works?

The following questions come from the platform research and should be answered in writing before application.

What exact legal entity, policy form, state-approved product, and rider names will appear on the application and contract ? Which specific Guardian whole life product is being quoted — ESWL, L95, L99, L121, 10 Pay WL, L20, or L65 — and is it currently available in the buyer's state [70]?

What are the guaranteed and current-assumption cash-surrender values at the end of years 1 through 10, and what percentage of cumulative premiums do they represent ? What is the exact cash value in year one, year two, and year three under the proposed design, and does any year have zero cash value ?

How much premium goes to the base policy versus the PUA rider in each year ? Are PUAs contractual, option-based, or dependent on dividend performance, and can the PUA amount be changed later ? What PUA funding schedule is allowed, what minimum contribution applies, and are unscheduled additions permitted [70]?

Would the proposed premium pattern cause a MEC, and what flexibility exists to avoid MEC status ? What are the specific MEC limits for the planned premium schedule [71]?

What is the current dividend scale, what portions are guaranteed, and how has the scale changed historically ? What is the current declared dividend rate versus the projected rate [71]?

What are the policy-loan interest rate, loan provisions, withdrawal rules, surrender charges, and lapse consequences ? How much lower will the dividend be on the borrowed portion under direct recognition, and when does that reduction apply ?

What exact charges apply to the Index Participation Feature, including caps, floors, negative adjustments, and restrictions on dividend options ? Is IPF available, what is the current cap and floor, and does the rider charge apply to all or only part of PUA value [70]?

Will the agent provide a side-by-side policy illustration comparing Guardian's design against a top competitor such as MassMutual, New York Life, or Penn Mutual under identical assumptions ?

Final AI Consensus Verdict

Guardian Life is a good fit for whole life insurance for high early cash value, with a significant qualification. All seven platforms that named a carrier in the ranking stage named Guardian, giving it a 100% share of included platform responses and an average listed rank of 2.14. Fit ratings split between "good" (anthropic, deepseek, openai, perplexity) and "strong" (google, grok, kimi).

The consensus case rests on structure, not on a published price. Guardian's participating whole life portfolio supports paid-up additions, dividend reinvestment, limited-payment designs, and substantial policy-design flexibility. Guardian reports strong financial-strength ratings and a long stated history of dividend payments [72].

The consensus caution is equally consistent. Guardian does not publish a universal early-cash-value schedule or consumer price, and actual results depend heavily on the selected base-to-PUA mix, underwriting, premium pattern, rider charges, dividend scale, and whether the policy becomes a MEC. Some policies may have little or no cash value in the first two years [74]. No verified public evidence establishes that Guardian produces the highest early cash value among competing whole life insurers. Platform agreement on a recommendation does not prove product quality, and it cannot substitute for comparing guaranteed and current-assumption illustrations against competing mutual insurers.

How This Review Was Produced

This review synthesizes fit-research responses from seven AI platforms — anthropic, deepseek, google, grok, kimi, openai, and perplexity — each asked which whole life insurance carriers they would recommend for a consumer prioritizing accessible cash value in the early policy years. The study date is 2026-09-20. Platform mentions count only platforms that named Guardian Life during ranking discovery; all seven included platforms named it.

Each platform supplied its own citations, fit rating, strengths, limitations, pricing notes, and verification questions. Those responses were consolidated into the sections above. Citations are platform-reported evidence, not independently verified facts. Company-owned sources are distinguished from independent sources in the Sources section. The two internal links in this article point to the Whole Life Insurance for High Early Cash Value consensus index and the broader life insurance category directory.

Methodology Limitations

Several limitations apply.

Platform-reported research dates differ from the authoritative run date of 2026-09-20. Six platforms reported 2026-09-21; deepseek reported 2026-01-15. Platform-reported dates are provenance metadata and do not independently prove freshness.

Deepseek ran with search disabled, so its claims rest on model knowledge rather than retrieved sources. Its citations include a partial-support A.M. Best link and an NAIC buyer's guide. No-search model claims require explicit verification before being described as current facts.

The supplied URLs were collected from platform responses and were not independently validated by the writer stage. Citations are platform-reported evidence, not independently verified facts.

Product naming conflicts were not resolved by guessing. The requested names "Executive Strategies Whole Life" and "Guardian L95 Whole Life with Enhanced Permanent Paid-Up Additions Rider" are only partially verified against Guardian's public broker page, which lists Executive Wealth Strategies Whole Life and Whole Life 95 [75]. Buyers should confirm exact policy forms.

Pricing is missing across platforms. No public consumer premium quote or standardized price was verified for the relevant Guardian whole-life designs, and pricing confidence was rated low by openai, deepseek, perplexity, and kimi, and moderate by anthropic and grok.

Some evidence comes from third-party distributor or brochure material rather than Guardian's main consumer pages, including the Enhanced Paid-Up Additions Rider brochure and the Executive Strategies Whole Life document. Those claims should be verified against the illustration and policy contract.

One or more fetched domains were not corroborated by brand name or site identity metadata and were not used as official identity signals. Company-name variants were collapsed onto one canonical brand before minimum-mentions qualification.

Sources

Company-Owned Sources

Independent Sources

Other Sources

  • What is the Index Participation Feature?1 — The IPF is an innovative rider: https://static.fmgsuite.com/media/documents/fc3988bd-6891-4899-b083-e3a198eca30c.pdf
  • Additional AI research evidence75 records
    1. AI research evidence record openai:guardian_broker_products
    2. AI research evidence record openai:guardian_riders
    3. AI research evidence record openai:guardian_financial_highlights
    4. AI research evidence record anthropic:41-3
    5. AI research evidence record openai:guardian_riders
    6. AI research evidence record openai:guardian_whole_life_how_it_works
    7. AI research evidence record google:citation_2
    8. AI research evidence record google:citation_5
    9. AI research evidence record anthropic:5-10
    10. AI research evidence record anthropic:5-11
    11. AI research evidence record kimi:betterwealth-2026-cash-value
    12. AI research evidence record perplexity:c9
    13. AI research evidence record openai:guardian_broker_products
    14. AI research evidence record anthropic:24-1
    15. AI research evidence record openai:guardian_riders
    16. AI research evidence record perplexity:c2
    17. AI research evidence record anthropic:23-1
    18. AI research evidence record anthropic:23-3
    19. AI research evidence record anthropic:16-3
    20. AI research evidence record anthropic:16-5
    21. AI research evidence record openai:guardian_dividends
    22. AI research evidence record anthropic:30-5
    23. AI research evidence record anthropic:45-3
    24. AI research evidence record anthropic:30-8
    25. AI research evidence record anthropic:34-3
    26. AI research evidence record openai:guardian_financial_highlights
    27. AI research evidence record anthropic:37-1
    28. AI research evidence record anthropic:37-2
    29. AI research evidence record anthropic:14-1
    30. AI research evidence record kimi:betterwealth-2026-cash-value
    31. AI research evidence record google:citation_2
    32. AI research evidence record anthropic:13-2
    33. AI research evidence record openai:guardian_whole_life
    34. AI research evidence record anthropic:20-17
    35. AI research evidence record perplexity:c8
    36. AI research evidence record openai:guardian_riders
    37. AI research evidence record anthropic:3-2
    38. AI research evidence record anthropic:14-12
    39. AI research evidence record anthropic:10-5
    40. AI research evidence record kimi:insuranceproblog-hecv
    41. AI research evidence record openai:guardian_riders
    42. AI research evidence record anthropic:19-1
    43. AI research evidence record perplexity:c5
    44. AI research evidence record openai:guardian_dividends
    45. AI research evidence record openai:guardian_whole_life_how_it_works
    46. AI research evidence record openai:guardian_broker_products
    47. AI research evidence record anthropic:5-11
    48. AI research evidence record anthropic:1-3
    49. AI research evidence record perplexity:c8
    50. AI research evidence record openai:guardian_tax
    51. AI research evidence record anthropic:1-12
    52. AI research evidence record deepseek:guardian_whole_life
    53. AI research evidence record anthropic:28-1
    54. AI research evidence record anthropic:44-11
    55. AI research evidence record kimi:betterwealth-2026-cash-value
    56. AI research evidence record kimi:insuranceandestates-guide
    57. AI research evidence record openai:guardian_riders
    58. AI research evidence record anthropic:3-2
    59. AI research evidence record anthropic:30-13
    60. AI research evidence record anthropic:41-3
    61. AI research evidence record perplexity:c9
    62. AI research evidence record kimi:betterwealth-2026-cash-value
    63. AI research evidence record anthropic:13-2
    64. AI research evidence record anthropic:10-1
    65. AI research evidence record anthropic:14-12
    66. AI research evidence record anthropic:44-11
    67. AI research evidence record anthropic:30-13
    68. AI research evidence record anthropic:44-11
    69. AI research evidence record kimi:betterwealth-2026-cash-value
    70. AI research evidence record perplexity:c9
    71. AI research evidence record kimi:betterwealth-2026-cash-value
    72. AI research evidence record openai:guardian_financial_highlights
    73. AI research evidence record openai:guardian_dividends
    74. AI research evidence record anthropic:13-2
    75. AI research evidence record openai:guardian_broker_products

Verify this research

Check when the research was run, which platforms were included, and what supports the findings.

Study date
September 20, 2026
Platforms analyzed
7
Source records
40
Ranking mentions
7 of 7
Platform share
100%
Final consensus rank
#1

Behind the findings

Platforms in this study

  • ChatGPT
  • Claude
  • DeepSeek
  • Grok
  • Perplexity
  • Kimi
  • Gemini

Source records

21 independent · 17 company-owned · 2 unclear

Evidence support

20 direct · 9 partial

Keep in mind

Use the run research_date as the study date. Platform-reported dates are provenance metadata and do not independently prove freshness.

Technical verification details

Use this SHA-256 fingerprint to identify the source snapshot associated with this study.

5994ea5d483444b674e18faf2f00cce3590573eb402538c1f5b5aa1bd4f23ea2